Scott Tagawa MD in New York, New York

Home New York New York

Scott Tagawa MD has Medical Oncology as his primary medical specialty. Their primary office is: 520 E 70th St in New York, New York.

They're a part of the: Weill Medical College Of Cornell medical group which has around 1,564 members. You can call their office at 646-962-2012 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Southern California Keck School Of Medicine and graduated in 1998 (around 26 years of experience). They are listed as doing telehealth appointments.

Scott T Tagawa MD Office Phone and Directions

Scott Tagawa MD
Weill Medical College Of Cornell
520 E 70th St
New York, New York 10021
646-962-2012

Patient Ratings
Please rate your experience with Scott Tagawa MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 646-962-2012

Enter a starting address:

Healthcare Info for Scott Tagawa MD

Additional Medical Specialties Include:
HEMATOLOGY

Medical School: University Of Southern California Keck School Of Medicine
Graduation Year: 1998
The Primary Medical Specialty for Scott Tagawa MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 26
PAC (PECOS ID)#: 1153420534
NPI #: 1245258045
NPI Created On: 07/18/2006
NPI Last Updated Listed as: 11/10/2011
Primary Taxonomy Code: 207RH0003X
License Number:
70818
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Vaccine for influenza for administration into muscle, 0.5 ml dosage
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
New patient office or other outpatient visit, typically 60 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Established patient office or other outpatient, visit typically 40 minutes
Subsequent hospital inpatient care, typically 35 minutes per day
Administration of influenza virus vaccine
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Injection, denosumab, 1 mg
Injection, degarelix, 1 mg
Leuprolide acetate (for depot suspension), 7.5 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $2,430

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 787613639

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $1,515

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788026889

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $72

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 790255707

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Rubraca

Open Associated Drug #1: 69660-201-91

Payments Total: $2,620

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 813302545

Being Disputed:: No

Product Related: Yes

Payments Total: $3,600

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: ;G2808718;ORTBIO;10264104

Record ID:: 845883741

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONC

Name of Drug #1: Trodelvy

Open Associated Drug #1: 55135-132-01

Payments Total: $3,000

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: ;G2808705;ORTBIO;10264104

Record ID:: 845883737

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONC

Name of Drug #1: Trodelvy

Open Associated Drug #1: 55135-132-01

Payments Total: $1,510

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: ;G2752493;BryanAllen;10264104

Record ID:: 845883739

Being Disputed:: No

Product Related: Yes

Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833164689

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: XTANDI

Open Associated Drug #1: 0469-0125-99

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: ORGOVYX

Associated Drug #2: 72974-120-01

Payments Total: $144

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833167815

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: XTANDI

Open Associated Drug #1: 0469-0125-99

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: ORGOVYX

Associated Drug #2: 72974-120-01

Payments Total: $212

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833197289

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: XTANDI

Open Associated Drug #1: 0469-0125-99

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: ORGOVYX

Associated Drug #2: 72974-120-01

Medical Oncology Professionals in New York

1.
Nevena Lucic

520 E 70th St
New-york, NY
Weill Medical College Of Cornell

2.
Aaron Stonestrom

1275 York Ave
New-york, NY
Memorial Hematology Lymphoma Group

3.
Michael Buchholtz

550 1st Ave
New-york, NY
New York University

4.
Krzysztof Misiukiewicz

5 E 98th St 12th Floor
New-york, NY
Icahn School Of Medicine At Mount Sinai

5.
Krzysztof Misiukiewicz

5 E 98th St
New-york, NY
Icahn School Of Medicine At Mount Sinai

6.
Stacy Stabler

1275 York Ave
New-york, NY
Memorial Neurology Group

Providers in Weill Medical College Of Cornell

1.Jaime Aaronson

525 E 68th St
New York Ny 10065-4870
Weill Medical College Of Cornell
Anesthesiology

2.Omar Abdul-rahman Md

525 E 68th St
New York Ny 10065-4870
Weill Medical College Of Cornell
Pediatric Medicine

3.Omar Abdul-rahman Md

525 E 68th St
New York Ny 10065-4870
Weill Medical College Of Cornell
Pediatric Medicine

4.Omar Abdul-rahman Md

505 E 70th St
New York Ny 10021-4872
Weill Medical College Of Cornell
Pediatric Medicine

5.Juveria Abdullah

525 E 68th St
New York Ny 10065-4870
Weill Medical College Of Cornell
Internal Medicine

6.Josyann Abisaab

525 E 68th St
New York Ny 10021-4870
Weill Medical College Of Cornell
Emergency Medicine

View all 1,564 members of Weill Medical College Of Cornell medical group